Cancer Research CTRC-AACR San Antonio Breast Cancer Symposium  Translational Medicine Conference in Israel
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 56, 3626-3629, August 15, 1996]
© 1996 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Venne, A.
Right arrow Articles by Alakhov, V.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Venne, A.
Right arrow Articles by Alakhov, V.

Hypersensitizing Effect of Pluronic L61 on Cytotoxic Activity, Transport, and Subcellular Distribution of Doxorubicin in Multiple Drug-resistant Cells1

Annie Venne, Shengmin Li, Rosemonde Mandeville, Alexander Kabanov2 and Valery Alakhov2

Immunology Research Center [A. V., S. L., R. M., V. A.] and Supratek Pharma, Inc. [V. A.], Institute Armand-Frappier, University of Quebec, 531 Boulevard des Prairies, Building 18, Laval, Quebec H7N 4Z3, Canada, and Department of Pharmaceutical Sciences, College of Pharmacy, University of Nebraska Medical Center, Omaha, Nebraska 68198-6025 [A. K.]

The present study demonstrated that poly(oxypropylene) and poly(oxyethylene) block copolymer pluronic L61 (L61)-hypersensitized multidrugresistant CHRC5 Chinese hamster ovary cells and MCF-7/ADR human breast carcinoma cells to the cytotoxic action of doxorubicin (Dox). CHRC5 and MCF-7/ADR cells manifested 290- and 700-fold increases, respectively, in their sensitivity to Dox/L61 formulation compared with free Dox. Their sensitive counterparts Aux-B1 and MCF-7 displayed only marginal or no increase at all in their response to Dox/L61. The study of the drug transport performed by flow cytometry showed that L61 enhanced the drug uptake and reduced the P-glycoprotein-mediated drug efflux. Visualization of Dox subcellular distribution in CHRC5 cells by fluorescent microscopy revealed that Dox was sequestered in cytoplasmic vesicles, whereas incubation of the cells with Dox/L61 altered the drug compartmentalization by releasing the drug from these vesicles and shifting it to the nucleus. These findings suggested that the hypersensitive response of multidrug-resistant cells to the action of Dox/L61 was caused by an increase in the drug accumulation and changes in its subcellular distribution.

1 This work was supported by Industrial Research Assistance Program (IRAP) Grant 14113Q from the National Research Council of Canada.

2 To whom requests for reprints should be addressed, at Supratek Pharma, Inc., c/o Institute Armand-Frappier, University of Quebec, 531 Boulevard des Prairies, Building 18, Immunology Research Center, Laval, Quebec H7N 4Z3, Canada; Phone: (514) 686-5502; Fax: (514) 686-5504; E-mail: Valery__Alakhov@IAF.UQUEBEC.CA (V. A.); or Department of Pharmaceutical Sciences, College of Pharmacy, University of Nebraska Medical Center, 600 South 42nd street, Omaha, NE 68198-6025; Phone: (402) 559-9364; Fax: (402) 559-5060; E-mail: Akabanov@UNMC.Edu. (A. K.)

Received 5/17/96. Accepted 7/ 3/96.




This article has been cited by other articles:


Home page
Cancer Res.Home page
C.-l. Dai, A. K. Tiwari, C.-P. Wu, X.-d. Su, S.-R. Wang, D.-g. Liu, C. R. Ashby Jr., Y. Huang, R. W. Robey, Y.-j. Liang, et al.
Lapatinib (Tykerb, GW572016) Reverses Multidrug Resistance in Cancer Cells by Inhibiting the Activity of ATP-Binding Cassette Subfamily B Member 1 and G Member 2
Cancer Res., October 1, 2008; 68(19): 7905 - 7914.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
H. Chen, S. Kim, L. Li, S. Wang, K. Park, and J.-X. Cheng
Release of hydrophobic molecules from polymer micelles into cell membranes revealed by Forster resonance energy transfer imaging
PNAS, May 6, 2008; 105(18): 6596 - 6601.
[Abstract] [Full Text] [PDF]


Home page
Exp. Biol. Med.Home page
T. M. Krupka, B. D. Weinberg, H. Wu, N. P. Ziats, and A. A. Exner
Effect of Intratumoral Injection of Carboplatin Combined with Pluronic P85 or L61 on Experimental Colorectal Carcinoma in Rats
Experimental Biology and Medicine, July 1, 2007; 232(7): 950 - 957.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
E. V. Batrakova, S. Li, V. Y. Alakhov, D. W. Miller, and A. V. Kabanov
Optimal Structure Requirements for Pluronic Block Copolymers in Modifying P-glycoprotein Drug Efflux Transporter Activity in Bovine Brain Microvessel Endothelial Cells
J. Pharmacol. Exp. Ther., February 1, 2003; 304(2): 845 - 854.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
E. V. Batrakova, S. Li, S. V. Vinogradov, V. Y. Alakhov, D. W. Miller, and A. V. Kabanov
Mechanism of Pluronic Effect on P-Glycoprotein Efflux System in Blood-Brain Barrier: Contributions of Energy Depletion and Membrane Fluidization
J. Pharmacol. Exp. Ther., November 1, 2001; 299(2): 483 - 493.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
E. V. Batrakova, D. W. Miller, S. Li, V. Y. Alakhov, A. V. Kabanov, and W. F. Elmquist
Pluronic P85 Enhances the Delivery of Digoxin to the Brain: In Vitro and in Vivo Studies
J. Pharmacol. Exp. Ther., April 13, 2001; 296(2): 551 - 557.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1996 by the American Association for Cancer Research.